Book short notes

BNF, Lexicomp and Stockley's Drug Interactions

Quick references for doses, cautions, special populations and interactions.

Reference books are not read cover to cover; they are where the exam's dosing, interaction and special-population facts live. These notes gather the patterns worth memorising.

How this book helps in the exam

  • Which interaction matters and what to do about it.
  • Dose adjustments in kidney or liver disease, pregnancy, children and older adults.
  • Drugs with narrow therapeutic ranges that need monitoring.

What the book covers

10 high-yield topics. Each has the points most often examined and links to practise them.

  1. 1How interactions happen

    • Most serious interactions are through CYP enzymes: inhibitors raise levels of the other drug, inducers lower them.
    • Strong inducers include rifampicin, carbamazepine, phenytoin and St John's wort.
    • Strong inhibitors include clarithromycin, ketoconazole, itraconazole, ritonavir and grapefruit juice.
    • Induction takes days to weeks to start and to wear off; inhibition is quick.
  2. 2High-risk interaction pairs

    • Warfarin with metronidazole, fluconazole, amiodarone or macrolides raises the INR.
    • Simvastatin with clarithromycin or itraconazole can cause rhabdomyolysis.
    • Methotrexate with trimethoprim or NSAIDs increases toxicity.
    • Nitrates with sildenafil cause severe hypotension.
  3. 3QT-prolonging drugs

    • Common culprits are macrolides, fluoroquinolones, antipsychotics, methadone, ondansetron and amiodarone.
    • Low potassium or magnesium increases the risk.
    • Combining two QT-prolonging drugs is avoided where possible.
    • Torsades de pointes is treated with IV magnesium.
  4. 4Serotonin syndrome and hyperkalaemia

    • Serotonin syndrome comes from combining SSRIs, SNRIs, tramadol, linezolid, triptans or MAO inhibitors.
    • It presents with agitation, clonus, sweating and fever.
    • Hyperkalaemia risk combines ACE inhibitors or ARBs, spironolactone, potassium supplements and trimethoprim.
    • Check potassium after starting any of these together.
  5. 5Narrow therapeutic index drugs

    • Digoxin, lithium, phenytoin, theophylline, warfarin, aminoglycosides, vancomycin and tacrolimus need careful monitoring.
    • Brand switching of some, such as tacrolimus, should be avoided or monitored.
    • Sample timing matters: troughs just before a dose, digoxin at least 6 hours after.
    • Interpret phenytoin levels with albumin in mind.
  6. 6Liver disease

    • High-extraction drugs and those cleared by the liver accumulate in cirrhosis.
    • Sedatives and opioids can trigger hepatic encephalopathy.
    • Avoid NSAIDs in cirrhosis because of bleeding and kidney injury.
    • Paracetamol is acceptable at reduced doses in most liver disease.
  7. 7Children

    • Doses are calculated by weight or body surface area; check against the maximum adult dose.
    • Aspirin is avoided under 16 because of Reye's syndrome.
    • Codeine is avoided in young children because of variable CYP2D6 metabolism.
    • Tetracyclines stain teeth and fluoroquinolones are used only when needed.
  8. 8Prescription abbreviations and dosing terms

    • Error-prone abbreviations such as 'U' for units should be written out in full.
    • Weekly methotrexate dosing is a classic source of fatal error.
    • Check the strength and formulation on every liquid prescription.
    • Tenfold errors are the most dangerous paediatric dosing mistake.
  9. 9Kidney impairment

    • References give dose bands by creatinine clearance or eGFR; check which one the band uses.
    • Renally cleared drugs with narrow ranges (aminoglycosides, lithium, digoxin) need the closest attention.
    • Some drugs lose effect in poor kidney function, such as nitrofurantoin in moderate to severe impairment.
    • Nephrotoxic combinations (NSAID, ACE inhibitor or ARB, diuretic) raise the risk of acute kidney injury.
  10. 10Pregnancy and breastfeeding references

    • Check the trimester: risks such as organ malformation are highest in the first trimester.
    • Drug transfer into milk depends on protein binding, lipid solubility, half-life and oral bioavailability in the infant.
    • Drugs given safely to neonates directly are usually acceptable in breastfeeding.
    • Premature and newborn infants are most at risk from drugs passed in milk.

These are PharmaPrep's own notes on the knowledge this book teaches. No text, tables or figures are reproduced from it. Read the book for full explanations, and check doses and laws against current official sources.

Test yourself on these topics

Free MCQs with explanations, mock tests and a daily quiz.

Start preparing free